Atlas Trials

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD

Clinical trial NCT01213992 · COMPLETED

Trial details

NCT number
NCT01213992
Sponsor
Pharmacosmos A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-dialysis Dependent Chronic Kidney Disease
Start date
2012-03-01
Primary completion
2012-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.